International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.13865127
Case Report
Caeserean Scar Ectopic Pregnancy –Series of 10 Cases
Published
Oct. 1, 2024
Abstract

Caeserean scar ectopic pregnancy (CSEP) is the rarest form of ectopic pregnancy with incidence of 1 in 2000 pregnancies. It requires high degree of suspicion and if not diagnosed and managed early, can result in maternal morbidity and mortality. Due to rise in rate of caesarean sections worldwide, therehas resulted anincrease in rate of caesarean scar ectopic pregnancies. Widespread availability of ultrasound services has helped in early diagnosis and timely management. Here we present 10 cases of Caesarean scar ectopic pregnancies that we have managed over period of 5 years (2018- 2023) in our tertiary care hospital. All cases were diagnosed by either transvaginal scan or transabdominal scan done at our hospital or done outside and then referred to us for management. There are different management options for caesarean scar ectopic pregnancy ranging from conservative to surgical treatment. Medical therapy is by using Inj Methotrexate 1mg /kg body weight intramuscular. Surgical treatment includes ultrasound guided suction evacuation, laparotomy, or laparoscopic excision of scar ectopic. Since the entity is rare, presentations vary, there is no fixed protocol of management of this condition. Patient may be benefited by surgery or sometimes medical management or there may be a combination of medical and surgical management. Traditionally laparotomy was done for removal of scar ectopic, however with advent of good ultrasound machines, wecould manage most cases using ultrasound guided suction evacuation alone. Very few cases required medical management and laparotomyhad to be done in two cases.

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
2817 Views
396 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved